|
ATL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.890420E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.119000E-01 |
| Normal-vs-Stage2 |
1.381000E-01 |
| Normal-vs-Stage3 |
5.792800E-01 |
| Normal-vs-Stage4 |
1.348490E-02 |
| Stage1-vs-Stage2 |
2.652200E-01 |
| Stage1-vs-Stage3 |
8.711000E-01 |
| Stage1-vs-Stage4 |
3.475700E-02 |
| Stage2-vs-Stage3 |
4.702200E-01 |
| Stage2-vs-Stage4 |
2.662000E-01 |
| Stage3-vs-Stage4 |
1.077970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.263990E-01 |
| Normal-vs-AfricanAmerican |
4.703200E-01 |
| Normal-vs-Asian |
9.593000E-01 |
| Caucasian-vs-AfricanAmerican |
8.165600E-01 |
| Caucasian-vs-Asian |
7.551400E-01 |
| AfricanAmerican-vs-Asian |
8.562200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.093850E-01 |
| Normal-vs-Female |
7.658000E-01 |
| Male-vs-Female |
5.526800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.585850E-02 |
| Normal-vs-Extreme_Weight |
6.097900E-02 |
| Normal-vs-Obese |
3.914400E-01 |
| Normal-vs-Extreme_Obese |
3.559000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.708600E-01 |
| Normal_Weight-vs-Obese |
1.981840E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.434800E-01 |
| Extreme_Weight-vs-Obese |
6.048800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.089800E-01 |
| Obese-vs-Extreme_Obese |
7.427600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.812010E-01 |
| Normal-vs-Age(41-60Yrs) |
8.898000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.193900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.458200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.822210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.853200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.684400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.422200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.865600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.533000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.819200E-01 |
| Normal-VS-Type2 PRCC |
3.726100E-02 |
| Normal-VS-KIRP CIMP |
4.44089209850063E-16 |
| Normal-VS-Unclassified PRCC |
5.970000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.445800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
6.402800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.66457991624247E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
1.148440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.93519999972069E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.161400E-01 |
| Normal-vs-N1 |
1.645640E-01 |
| Normal-vs-N2 |
1.316420E-01 |
| N0-vs-N1 |
7.303600E-01 |
| N0-vs-N2 |
2.153000E-01 |
| N1-vs-N2 |
2.517400E-01 |
|
|
